D.E. Shaw & Co’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,550
| Closed | -$54.9K | – | 3691 |
|
|
2022
Q4 | $54.9K | Sell |
1,550
-1,857
| -55% | -$65.7K | ﹤0.01% | 3187 |
|
|
2022
Q3 | $770K | Sell |
3,407
-5,153
| -60% | -$1.16M | ﹤0.01% | 2677 |
|
|
2022
Q2 | $1.62M | Sell |
8,560
-2,642
| -24% | -$499K | ﹤0.01% | 2393 |
|
|
2022
Q1 | $2.79M | Buy |
11,202
+10,236
| +1,060% | +$2.55M | ﹤0.01% | 2190 |
|
|
2021
Q4 | $150K | Buy |
+966
| New | +$150K | ﹤0.01% | 3567 |
|
|
2021
Q1 | – | Sell |
-777
| Closed | -$286K | – | 3248 |
|
|
2020
Q4 | $286K | Sell |
777
-2,436
| -76% | -$897K | ﹤0.01% | 2468 |
|
|
2020
Q3 | $785K | Sell |
3,213
-4,047
| -56% | -$989K | ﹤0.01% | 1975 |
|
|
2020
Q2 | $2.09M | Buy |
7,260
+4,746
| +189% | +$1.37M | ﹤0.01% | 1589 |
|
|
2020
Q1 | $513K | Buy |
2,514
+663
| +36% | +$135K | ﹤0.01% | 2137 |
|
|
2019
Q4 | $827K | Buy |
1,851
+1,369
| +284% | +$612K | ﹤0.01% | 1994 |
|
|
2019
Q3 | $148K | Buy |
+482
| New | +$148K | ﹤0.01% | 2432 |
|
|
2015
Q2 | – | Sell |
-57
| Closed | -$489K | – | 2759 |
|
|
2015
Q1 | $489K | Buy |
57
+14
| +33% | +$120K | ﹤0.01% | 2071 |
|
|
2014
Q4 | $375K | Buy |
43
+1
| +2% | +$8.72K | ﹤0.01% | 2122 |
|
|
2014
Q3 | $196K | Buy |
+42
| New | +$196K | ﹤0.01% | 2202 |
|